Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2011-4-27
pubmed:abstractText
Prader-Willi syndrome (PWS) is a multisystem disorder caused by genetic loss of function of a cluster of imprinted, paternally expressed genes. Neonatal failure to thrive in PWS is followed by childhood-onset hyperphagia and obesity among other endocrine and behavioral abnormalities. PWS is typically assumed to be caused by an unknown hypothalamic-pituitary dysfunction, but the underlying pathogenesis remains unknown. A transgenic deletion mouse model (TgPWS) has severe failure to thrive, with very low levels of plasma insulin and glucagon in fetal and neonatal life prior to and following onset of progressive hypoglycemia. In this study, we tested the hypothesis that primary deficits in pancreatic islet development or function may play a fundamental role in the TgPWS neonatal phenotype. Major pancreatic islet hormones (insulin, glucagon) were decreased in TgPWS mice, consistent with plasma levels. Immunohistochemical analysis of the pancreas demonstrated disrupted morphology of TgPWS islets, with reduced ?- and ?-cell mass arising from an increase in apoptosis. Furthermore, in vivo and in vitro studies show that the rate of insulin secretion is significantly impaired in TgPWS ?-cells. In TgPWS pancreas, mRNA levels for genes encoding all pancreatic hormones, other secretory factors, and the ISL1 transcription factor are upregulated by either a compensatory response to plasma hormone deficiencies or a primary effect of a deleted gene. Our findings identify a cluster of imprinted genes required for the development, survival, coordinate regulation of genes encoding hormones, and secretory function of pancreatic endocrine cells, which may underlie the neonatal phenotype of the TgPWS mouse model.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1522-1555
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
300
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
E909-22
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:21343540-Animals, pubmed-meshheading:21343540-Blood Glucose, pubmed-meshheading:21343540-C-Peptide, pubmed-meshheading:21343540-Caspase 3, pubmed-meshheading:21343540-Cell Proliferation, pubmed-meshheading:21343540-Female, pubmed-meshheading:21343540-Gene Deletion, pubmed-meshheading:21343540-Glucagon, pubmed-meshheading:21343540-Glucagon-Secreting Cells, pubmed-meshheading:21343540-Immunohistochemistry, pubmed-meshheading:21343540-Insulin, pubmed-meshheading:21343540-Insulin-Secreting Cells, pubmed-meshheading:21343540-Islets of Langerhans, pubmed-meshheading:21343540-Mice, pubmed-meshheading:21343540-Mice, Knockout, pubmed-meshheading:21343540-Microarray Analysis, pubmed-meshheading:21343540-Prader-Willi Syndrome, pubmed-meshheading:21343540-Pregnancy, pubmed-meshheading:21343540-RNA, Messenger, pubmed-meshheading:21343540-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:21343540-Somatostatin
pubmed:year
2011
pubmed:articleTitle
Global deficits in development, function, and gene expression in the endocrine pancreas in a deletion mouse model of Prader-Willi syndrome.
pubmed:affiliation
Dept. of Pediatrics, Children's Hospital of Pittsburgh of UPMC, Rangos Research Bldg., 4401 Penn Ave., Pittsburgh, PA 15224, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural